MIXED HEPATOCELLULAR CHOLANGIOCARCINOMA

MIXED HEPATOCELLULAR CHOLANGIOCARCINOMA was reported 45 times

MIXED HEPATOCELLULAR CHOLANGIOCARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 22 0.0002
1 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 4 0.0002
2 Vascular Endothelial Growth Factor Inhibitor [EPC] 22 0.0001
3 Provitamin D2 Compound [EPC] 2 0.0001
4 HER2/neu Receptor Antagonist [EPC] 4 0.0001
5 Estrogen Receptor Antagonist [EPC] 2 0.0000
6 Bile Acid [EPC] 1 0.0000
7 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 2 0.0000
8 Aldosterone Antagonist [EPC] 5 0.0000
9 Interleukin-17A Antagonist [EPC] 1 0.0000
10 Polyene Antifungal [EPC] 1 0.0000
11 Platinum-based Drug [EPC] 6 0.0000
12 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
13 Kinase Inhibitor [EPC] 10 0.0000
14 Nucleoside Analog Antiviral [EPC] 1 0.0000
15 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
16 Interleukin-12 Antagonist [EPC] 1 0.0000
17 Interleukin-23 Antagonist [EPC] 1 0.0000
18 Tumor Necrosis Factor Blocker [EPC] 8 0.0000
19 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
20 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
21 Factor Xa Inhibitor [EPC] 2 0.0000
22 Calcium [EPC] 1 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
24 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
25 Interferon beta [EPC] 1 0.0000
26 Vitamin C [EPC] 2 0.0000
27 Osmotic Laxative [EPC] 1 0.0000
28 Vitamin D [EPC] 1 0.0000
29 Vitamin B12 [EPC] 1 0.0000
30 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
31 Corticosteroid [EPC] 3 0.0000
32 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
33 Insulin Analog [EPC] 1 0.0000
34 Proton Pump Inhibitor [EPC] 1 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000